Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

February 28, 1998

Study Completion Date

April 30, 2004

Conditions

ANCA Associated Systemic VasculitisWegener's GranulomatosisMicroscopic Polyangiitis

Interventions

DRUG

cyclophosphamide

All Listed Sponsors

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT00430105 - Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides | Biotech Hunter | Biotech Hunter